"Juego de LLaves": Study Protocol of a Universal School-based Drug Use Prevention Program (PSIDUP) (PSIDUP)

June 28, 2022 updated by: Susana Al-Halabí

"Juego de Llaves", a Universal School-based Drug Use Prevention Program: A Non-Randomized Control Cluster Trial for the Evaluation of Effectiveness Among Adolescents in Spain (PISUP)

"Juego de Llaves" is a universal school-based drug prevention program for adolescents aged 12-15 years. The outcome evaluation is critical to determine the quality of preventive interventions. This protocol describes the full protocol of the evaluation design, instruments, randomization procedure, follow-ups, and primary outcomes. Method: Non-Randomized Control Cluster Trial in a set of Spanish school centers at the compulsory secondary education level, with follow-ups at 12-, 24- and 36-months. Participants will be allocated to an experimental or control (no intervention) group. Using an electronic ad-hoc designed App, a battery of instruments will be used to assess addictive behaviors, sociodemographic variables, school climate and other transdiagnostic psychological variables. A piloting test will be conducted to test the implementation protocol and to calculate the sample size needed for the outcome evaluation. After implementing the program, longitudinal statistical approaches will be used to inform on the intervention efficacy and potential moderators and mediators. There is a lack of effectiveness assessments of school prevention programs, and it is expected that this protocol will expedite the monitoring and ongoing evaluation in prevention.

Study Overview

Study Type

Interventional

Enrollment (Anticipated)

2500

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • Asturias
      • Oviedo, Asturias, Spain, 33006
        • Grupo de Conductas Adictivas, University of Oviedo

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

12 years to 15 years (Child)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Schools having secondary education.
  • Schools located in Spain.
  • Schools willing to participate under the conditions of the study before randomization.

Exclusion Criteria:

  • Schools having other interventions with a strong package on substance use prevention targeted the same grades.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Non-Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Juego de Llaves group

This group will receive the prevention program during the academic year in school hours. The prevention program is called Juego de Llaves.

The main goal of this program is to prevent substance use and engagement in other addictive behaviors. It is intended to be delivered by teachers in a six to twelve session format through different modules that cover the following areas: emotional regulation, cognitive strategies, social interaction, free time, education on drugs and life values

The main goal of this program is to prevent substance use and engagement in other addictive behaviors. It is intended to be delivered by teachers in a six to twelve session format through different modules that cover the following areas: emotional regulation, cognitive strategies, social interaction, free time, education on drugs and life values
No Intervention: Control group
The control group will receive the usual teaching activities regarding substance use prevention.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Substance use: Tobacco
Time Frame: Past 30-day period
Ítems from the survey on drug use in secondary education in Spain (ESTUDES) for the National Plan on Drugs
Past 30-day period
Substance use: Alcohol
Time Frame: Past 30-day period
Ítems from the survey on drug use in secondary education in Spain (ESTUDES) for the National Plan on Drugs
Past 30-day period
Substance use: Cannabis
Time Frame: Past 30-day period
Ítems from the survey on drug use in secondary education in Spain (ESTUDES) for the National Plan on Drugs
Past 30-day period
Non-substance use behavior: Gaming
Time Frame: Past 30-day period
Ítems from the survey on drug use in secondary education in Spain (ESTUDES) for the National Plan on Drugs
Past 30-day period
Non-substance use behavior: Gambling
Time Frame: Past 30-day period
Ítems from the survey on drug use in secondary education in Spain (ESTUDES) for the National Plan on Drugs
Past 30-day period
Reinforcement ratio
Time Frame: Past-year period
Ad-hoc questionnaire (SAUPI; unpublished)
Past-year period
Consecuences of addictive behaviors
Time Frame: Past 30-day period
ARSS-SUV (adapted from Murphy et al., 2005)
Past 30-day period

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Resilience
Time Frame: Past 30-day period
The Child and Youth Resilience Measure, CYMR (Resilience Research Centre, 2018)
Past 30-day period
Behavioral problemas
Time Frame: Past 30-day period
Strengths and Difficulties Questionnaire (25-item version), SDQ (Ortuño-Sierra et al., 2018)
Past 30-day period
Emotion regulation
Time Frame: Past 30-day period
The Emotional Regulation Questionnaire - adolescents, ERQ-CA (Navarro et al., 2018)
Past 30-day period
Suicidal behavior
Time Frame: Past 30-day period
The Paykel Suicide Scale, PSS (Fonseca-Pedrero et al., 2018)
Past 30-day period
Impulsivity
Time Frame: Past 30-day period
The Scale of Impulsivity for Children and Adolescents BUPPS-P-NA (Caneto et al., 2020)
Past 30-day period

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Helpful Links

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Anticipated)

September 1, 2022

Primary Completion (Anticipated)

June 30, 2023

Study Completion (Anticipated)

December 30, 2025

Study Registration Dates

First Submitted

June 15, 2022

First Submitted That Met QC Criteria

June 28, 2022

First Posted (Actual)

July 1, 2022

Study Record Updates

Last Update Posted (Actual)

July 1, 2022

Last Update Submitted That Met QC Criteria

June 28, 2022

Last Verified

June 1, 2022

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Behavior, Addictive

Clinical Trials on Juego de Llaves

Subscribe